Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of Drug-Drug Interactions of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor, With Transporter Substrates Based on In Vitro and Clinical Studies. | J Clin Pharmacol | 2023 | 37043676 | PubTator, text mining | PubMed |
| Characterization of ligand-induced thermal stability of the human organic cation transporter 2 (OCT2). | Front Pharmacol | 2023 | 37007010 | PubTator, text mining | PubMed |
| The inhibitory and inducing effects of ritonavir on hepatic and intestinal CYP3A and other drug-handling proteins. | Biomed Pharmacother | 2023 | 37004323 | PubTator, text mining | PubMed |
| The Preclinical Pharmacology of Tepotinib-A Highly Selective MET Inhibitor with Activity in Tumors Harboring MET Alterations. | Mol Cancer Ther | 2023 | 36999986 | PubTator, text mining | PubMed |
| Change of metformin concentrations in the liver as a pharmacological target site of metformin after long-term combined treatment with ginseng berry extract. | Front Pharmacol | 2023 | 36998615 | PubTator, text mining | PubMed |
| Deletion of NADPH oxidase 2 attenuates cisplatin-induced acute kidney injury through reducing ROS-induced proximal tubular cell injury and inflammation. | Front Med (Lausanne) | 2023 | 36993800 | PubTator, text mining | PubMed |
| Mechanisms of theaflavins against gout and strategies for improving the bioavailability. | Phytomedicine | 2023 | 36990009 | PubTator, text mining | PubMed |
| Photobiomodulation in Alzheimer's Disease-A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine? | Pharmaceutics | 2023 | 36986776 | PubTator, text mining | PubMed |
| Possible Side Effects of Polyphenols and Their Interactions with Medicines. | Molecules | 2023 | 36985507 | PubTator, text mining | PubMed |
| Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers. | J Pers Med | 2023 | 36983671 | PubTator, text mining | PubMed |
| Modulation of Endothelial Function by TMAO, a Gut Microbiota-Derived Metabolite. | Int J Mol Sci | 2023 | 36982880 | PubTator, text mining | PubMed |
| Pancreas-Liver-Adipose Axis: Target of Environmental Cadmium Exposure Linked to Metabolic Diseases. | Toxics | 2023 | 36976988 | PubTator, text mining | PubMed |
| Recent Advances in Decellularized Matrix-Derived Materials for Bioink and 3D Bioprinting. | Gels | 2023 | 36975644 | PubTator, text mining | PubMed |
| Preclinical assessment of drug-drug interaction of fb-PMT, a novel anti-cancer thyrointegrin αvβ3 antagonist. | Clin Transl Sci | 2023 | 36967488 | PubTator, text mining | PubMed |
| ATP/ADP biosensor organoids for drug nephrotoxicity assessment. | Front Cell Dev Biol | 2023 | 36936695 | PubTator, text mining | PubMed |
| Significant impact of time-of-day variation on metformin pharmacokinetics. | Diabetologia | 2023 | 36930251 | PubTator, text mining | PubMed |
| Degranulation of Murine Resident Cochlear Mast Cells: A Possible Factor Contributing to Cisplatin-Induced Ototoxicity and Neurotoxicity. | Int J Mol Sci | 2023 | 36902051 | PubTator, text mining | PubMed |
| Investigating a Library of Flavonoids as Potential Inhibitors of a Cancer Therapeutic Target MEK2 Using in Silico Methods. | Int J Mol Sci | 2023 | 36901876 | PubTator, text mining | PubMed |
| Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy. | Cancers (Basel) | 2023 | 36900216 | PubTator, text mining | PubMed |
| Imputation-powered whole-exome analysis identifies genes associated with kidney function and disease in the UK Biobank. | Nat Commun | 2023 | 36890159 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=15